...
mrna-img

Moderna Inc, Common Stock

MRNA

NSQ

$39.304

+$0.94

(2.45%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$15.69B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.41M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.69
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$35.8 L
$170.47 H
$39.304

About Moderna Inc, Common Stock

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameMRNASectorS&P500
1-Week Return-7.61%-3.35%-2.97%
1-Month Return6.09%-3.49%-0.66%
3-Month Return-41.84%-12.6%2.71%
6-Month Return-70.57%-6.91%7.21%
1-Year Return-55.6%1.19%23.04%
3-Year Return-85.69%-0.21%28.43%
5-Year Return103.81%33.09%82.88%
10-Year Return112.69%93.55%184.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue48.04M274.49M17.74B19.26B6.85B[{"date":"2019-12-31","value":0.25,"profit":true},{"date":"2020-12-31","value":1.42,"profit":true},{"date":"2021-12-31","value":92.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.55,"profit":true}]
Cost of Revenue496.31M7.93M2.62B5.42B4.69B[{"date":"2019-12-31","value":9.16,"profit":true},{"date":"2020-12-31","value":0.15,"profit":true},{"date":"2021-12-31","value":48.32,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":86.65,"profit":true}]
Gross Profit48.04M266.56M15.12B13.85B2.15B[{"date":"2019-12-31","value":0.32,"profit":true},{"date":"2020-12-31","value":1.76,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.59,"profit":true},{"date":"2023-12-31","value":14.25,"profit":true}]
Gross Margin100.00%97.11%85.24%71.88%31.47%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":97.11,"profit":true},{"date":"2021-12-31","value":85.24,"profit":true},{"date":"2022-12-31","value":71.88,"profit":true},{"date":"2023-12-31","value":31.47,"profit":true}]
Operating Expenses593.76M1.03B1.82B4.43B6.39B[{"date":"2019-12-31","value":9.29,"profit":true},{"date":"2020-12-31","value":16.1,"profit":true},{"date":"2021-12-31","value":28.51,"profit":true},{"date":"2022-12-31","value":69.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(545.72M)(763.14M)13.30B9.42B(4.24B)[{"date":"2019-12-31","value":-4.1,"profit":false},{"date":"2020-12-31","value":-5.74,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.85,"profit":true},{"date":"2023-12-31","value":-31.88,"profit":false}]
Total Non-Operating Income/Expense62.92M33.46M7.00M355.00M660.00M[{"date":"2019-12-31","value":9.53,"profit":true},{"date":"2020-12-31","value":5.07,"profit":true},{"date":"2021-12-31","value":1.06,"profit":true},{"date":"2022-12-31","value":53.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(514.72M)(744.51M)13.29B9.57B(3.94B)[{"date":"2019-12-31","value":-3.87,"profit":false},{"date":"2020-12-31","value":-5.6,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.07,"profit":true},{"date":"2023-12-31","value":-29.67,"profit":false}]
Income Taxes(695.00K)2.55M1.08B1.21B772.00M[{"date":"2019-12-31","value":-0.06,"profit":false},{"date":"2020-12-31","value":0.21,"profit":true},{"date":"2021-12-31","value":89.28,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.64,"profit":true}]
Income After Taxes(514.02M)(747.06M)12.20B8.36B(4.71B)[{"date":"2019-12-31","value":-4.21,"profit":false},{"date":"2020-12-31","value":-6.12,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.53,"profit":true},{"date":"2023-12-31","value":-38.63,"profit":false}]
Income From Continuous Operations(514.02M)(747.06M)12.20B8.36B(3.47B)[{"date":"2019-12-31","value":-4.21,"profit":false},{"date":"2020-12-31","value":-6.12,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.53,"profit":true},{"date":"2023-12-31","value":-28.41,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(514.02M)(747.06M)12.20B8.36B(4.71B)[{"date":"2019-12-31","value":-4.21,"profit":false},{"date":"2020-12-31","value":-6.12,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.53,"profit":true},{"date":"2023-12-31","value":-38.63,"profit":false}]
EPS (Diluted)(1.55)(1.94)28.2919.96(12.41)[{"date":"2019-12-31","value":-5.48,"profit":false},{"date":"2020-12-31","value":-6.86,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.55,"profit":true},{"date":"2023-12-31","value":-43.87,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MRNA
Cash Ratio 0.75
Current Ratio 4.39
Quick Ratio 4.20

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MRNA
ROA (LTM) -9.55%
ROE (LTM) -17.52%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MRNA
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MRNA
Trailing PE NM
Forward PE 32.47
P/S (TTM) 3.09
P/B 1.35
Price/FCF NM
EV/R 2.09
EV/Ebitda 4.64
PEG NM

FAQs

What is Moderna Inc share price today?

Moderna Inc (MRNA) share price today is $39.304

Can Indians buy Moderna Inc shares?

Yes, Indians can buy shares of Moderna Inc (MRNA) on Vested. To buy Moderna Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MRNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Moderna Inc be purchased?

Yes, you can purchase fractional shares of Moderna Inc (MRNA) via the Vested app. You can start investing in Moderna Inc (MRNA) with a minimum investment of $1.

How to invest in Moderna Inc shares from India?

You can invest in shares of Moderna Inc (MRNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in MRNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Moderna Inc shares
What is Moderna Inc 52-week high and low stock price?

The 52-week high price of Moderna Inc (MRNA) is $170.47. The 52-week low price of Moderna Inc (MRNA) is $35.8.

What is Moderna Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Moderna Inc (MRNA) is

What is Moderna Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Moderna Inc (MRNA) is 1.35

What is Moderna Inc dividend yield?

The dividend yield of Moderna Inc (MRNA) is 0.00%

What is the Market Cap of Moderna Inc?

The market capitalization of Moderna Inc (MRNA) is $15.69B

What is Moderna Inc’s stock symbol?

The stock symbol (or ticker) of Moderna Inc is MRNA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top